COURAGE CAPITAL MANAGEMENT LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 47 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
COURAGE CAPITAL MANAGEMENT LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$141,000
-0.7%
22,126
-26.2%
0.10%
-2.8%
Q1 2018$142,000
-15.0%
30,000
-40.0%
0.11%
-9.2%
Q4 2017$167,000
-39.9%
50,000
-61.5%
0.12%
-36.0%
Q3 2017$278,000
-13.1%
130,0000.0%0.19%
+12.7%
Q2 2017$320,000
+7.0%
130,0000.0%0.16%
-32.9%
Q1 2017$299,000
+135.4%
130,0000.0%0.25%
+211.4%
Q4 2016$127,000
-13.6%
130,0000.0%0.08%
+38.6%
Q3 2016$147,000130,0000.06%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$276,0000.10%
Geneos Wealth Management Inc. 445,200$725,0000.05%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$20,0000.01%
Vivaldi Capital Management LP 19,261$30,0000.01%
Atria Wealth Solutions, Inc. 278,700$454,2810.01%
OSAIC HOLDINGS, INC. 1,302,122$2,123,0000.01%
BARRETT & COMPANY, INC. 4,984$5,6320.00%
Ameritas Advisory Services, LLC 45,302$74,0000.00%
CENTAURUS FINANCIAL, INC. 20,732$34,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 19,255$31,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders